Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 16
A HarrisMartin Interview with W. Mark Lanier: Lead Plaintiff's Counsel in Ernst Discusses the Trial and Life After the Landmark Verdict
Arthritis Drugs In the Medical Literature This Month
Georgia Plaintiff Says Enbrel Caused Multiple Sclerosis
Iowa Plaintiff Blames Remicade for Brain Damage
Arthritis Drugs - Issue: 17
Causes of Action in Aleve-Heart Attack Suit Dismissed by Federal Judge
Judge Calls Merck Forum Argument 'Ludicrous,' Refuses to Dismiss Case
Judge Refuses to Dismiss Bextra Case Based on Intermediary, Pleading Arguments
New Jersey Law Will Apply to Vioxx Case, Merck Denied Summary Judgment
